Opentrons
We make robots for biologists.
New York, United States · Founded 2014 · $250.8M raised
- Headquarters
- New York, New York
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Website
- opentrons.com
- Total Funding
- $250.8M
- Last Round
- $20.1M Extension RoundNov 2025
- Rounds
- 7
About
Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data. That's why we started Opentrons. We make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions.
Summary
Opentrons is a Biotech company based in New York, United States, founded in 2014. It has raised $250.8M in total across 7 rounds, most recently a $20.1M Extension Round round in Nov 2025. Investors include Khosla Ventures, SOSV and Y Combinator Continuity Fund.
Tech & App Stack
10 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...


.png)
